Laura McLane - McDermott Will & Emery


Laura McLane heads the Boston Litigation Practice Group and is a nationally renowned False Claims Act (FCA) litigator. For more than 20 years, Laura has defended companies touching all aspects of the healthcare and life sciences industries in government investigations, qui tam litigation under the FCA, and related matters. Clients call Laura “an exquisite lawyer, very smart and incisive” and a “fierce advocate for her clients” (Chambers USA).

Show More


  • Represented the defendant in the groundbreaking Escobar case during which Laura obtained a writ of certiorari from the United States Supreme Court, after which the Court unanimously reversed an adverse decision of the court of appeals in the most important FCA decision in decades
  • Defends healthcare providers and other healthcare entities spanning all sectors, such as hospitals, ambulatory surgery centers, laboratories, urgent care, emergency medicine, telemedicine, dentistry, dialysis, behavioral health, as well as medical device manufacturers, pharmaceutical manufacturers, healthcare investors, Medicare Advantage brokers, and others in government investigations and qui tam litigation under the False Claims Act and related statutes, including the Anti-Kickback Statute and the Stark Law
  • Successfully advocated on behalf of numerous clients in persuading the government to decline to intervene or pursue claims under the FCA and related statutes

Show More


  • Chambers USA, Litigation: White-Collar Crime & Government Investigations, 2021-2024
  • Legal 500 US, 2020-2024
  • The Best Lawyers in America, Healthcare Law, Boston, 2019-2024
  • The Best Lawyers in America, Litigation – Healthcare, Boston, 2019-2024
  • Who’s Who Legal: Healthcare, 2021


Boston University School of Law, JD, cum laude, 1999
Emory University, BA, 1996


Show More